<DOC>
	<DOCNO>NCT01023841</DOCNO>
	<brief_summary>This study evaluate safety efficacy bimatoprost solution 0.03 % daily application upper eyelid margin compare vehicle treat eyelash loss hypotrichosis ( inadequate enough eyelash ) child .</brief_summary>
	<brief_title>Safety Efficacy Bimatoprost Solution Treating Eyelash Loss Hypotrichosis Children</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Hypotrichosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Children inadequate eyelash lose eyelash result chemotherapy treatment , complete chemotherapy ( intensive treatment ) least 4 week start study , consider low risk relapse cancer , well enough complete study Children minimal moderate inadequate eyelash due alopecia areata Adolescents age 1517 year minimal mark inadequate eyelash Any eye disease abnormality , eye surgery , permanent eyeliner , eyelash implant . Semipermanent eyelash tint , dye eyelash extension application within 3 month Use counter eyelash growth product within 6 month . Use prescription eyelash growth product ( eg , LatisseÂ® ) Any eye condition would prevent required ophthalmology exam</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>